NCT01796197 2026-02-05
Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa
Dana-Farber Cancer Institute
Phase 2 Completed
Dana-Farber Cancer Institute
Beni-Suef University
Indiana University
University College, London
Kahramanmaras Sutcu Imam University
Albert Einstein College of Medicine
Amgen
Karolinska University Hospital
University of Arkansas
Vanderbilt-Ingram Cancer Center